Addiction Treatment - Articles - Page 19

How to Talk to Patients About the Risk of Opioid Overdose

February 11, 2020

How do you engage patients in discussion surrounding overdose risk? Learn some evidence-based strategies that will build trust, be accessible and understandable to patients, and empower them to use as safely as possible.

New Hope: CBT for Internet and Computer Game Addiction

February 11, 2020

Jason Mallo, DO

Jason Mallo, DO Dr. Mallo has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Internet and computer game addictions represent difficult-to-define and difficult-to-treat conditions that are increasing in prevalence. To provide some guidance on treatment options, investigators tested short-term cognitive behavioral therapy in a randomized, controlled trial.

Learning Objectives, Harm Reduction, CATR, January/February 2020

February 11, 2020

After reading these articles, you should be able to…

CME Post-Test - Harm Reduction, CATR, January/February 2020

February 11, 2020

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME credit.

CLINICAL UPDATE

Primer: Physical Examination in Addiction Practice

November 22, 2019

Whether you are referring your patient for a physical or doing an initial one yourself, clinicians should be familiar with the basics of physical examination with a focus on knowing how to look for medical complications of addiction. This article walks you through a basic physical exam and what signs and symptoms to look for in patients with current or past substance use.

Screening and Prophylaxis of Infectious Diseases in Addiction Practice

November 22, 2019

Sandra Springer, MD

Sandra Springer, MD

Associate Professor of Medicine in the Department of Internal Medicine, Yale School of Medicine. Director of the Infectious Disease Clinic (Newington) and Attending Infectious Disease Physician (West Haven), VA Connecticut Healthcare System.

Dr. Springer has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this QA, we invite Dr. Sandra Springer to walk us through the various screenings for infectious diseases ranging from HIV to Hepatitis A, Hepatitis B, and Hepatitis C, as well as Tuberculosis.

PrEP: Introduction to the Basics

November 22, 2019

With the rate of new HIV infections at just under 40,000 new infections per year, it is important for addiction practitioners to be on the front lines of HIV prevention. This article and corresponding table cover the pre-exposure prophylaxis (PrEP) with Truvada.

Perioperative Management of Patients on Buprenorphine Maintenance

November 22, 2019

Gregory Acampora, MD

Gregory Acampora, MD

Psychiatrist, Pain Management Center, Massachusetts General Hospital/Harvard Center for Addiction Medicine, Boston, MA. Assistant Professor, Harvard Medical School.

Dr. Acampora has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

For patients on buprenorphine maintenance facing surgery, it is crucial to balance the need to minimize pain while addressing the risk of relapse. In this interview, Dr. Gregory Acampora guides us through the specifics on perioperatively managing patients on varying doses of buprenorphine maintenance.

Exposure Therapy Efficacious for PTSD Co-Occurring With Alcohol Use Disorder

November 22, 2019

Brian Frankel, MD

Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Prolonged exposure is one of the best treatments available for patients with PTSD. This study examines the advantages of using prolonged exposure for patients who have PTSD with co-occurring alcohol use disorder.

Varenicline and Bupropion: Soaring Again With EAGLES?

November 22, 2019

Nicholas Rosenlicht, MD.

Nicholas Rosenlicht, MD. Dr. Rosenlicht has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This research update unpacks the details behind the landmark “EAGLES” trial (Evaluating Adverse Events in a Global Smoking Cessation Study), which led to the removal of the varenicline black box warning.

Addiction Treatment
RSS

How to Talk to Patients About the Risk of Opioid Overdose

New Hope: CBT for Internet and Computer Game Addiction

Learning Objectives, Harm Reduction, CATR, January/February 2020

CME Post-Test - Harm Reduction, CATR, January/February 2020

Primer: Physical Examination in Addiction Practice

Screening and Prophylaxis of Infectious Diseases in Addiction Practice

PrEP: Introduction to the Basics

Perioperative Management of Patients on Buprenorphine Maintenance

Exposure Therapy Efficacious for PTSD Co-Occurring With Alcohol Use Disorder

Varenicline and Bupropion: Soaring Again With EAGLES?

Treating Opioid Use Disorder—A Fact Book (2024)

KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

A Scam for Every Woman, Child, and Man: Part 2

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us

Addiction Treatment RSS

About

Shop Online

Newsletters

Contact

Follow Us

Addiction Treatment
RSS